Clin2
NCT07684833Possibly a fitNot yet recruiting

Study of a tablet for chronic venous disease

Chronic Venous DiseaseVein DiseaseVenous Insufficiency of Leg

Part of Heart & circulation clinical trials.

This study tests a new tablet (called Heparan Sulfate) to see if it can improve symptoms and signs of chronic venous disease, a condition where leg veins have trouble sending blood back to the heart. It is a randomized, placebo-controlled trial, meaning some participants will receive the study tablet and some will receive a placebo (a tablet with no active medication).

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
174 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You have been diagnosed with chronic venous disease in your legs, with visible signs like varicose veins or skin changes, and confirmed by a type of ultrasound (duplex ultrasonography).
  • You have symptoms like pain, heaviness, or swelling, and your condition is not mild (score of 4 or more on a standard scale).
  • You are not currently using compression therapy (like compression stockings) and you are willing to not use it during the trial.
  • You have not used a venoactive drug (a medication for vein issues) in the last month.
  • You do not have severe heart, liver, or kidney problems, and you are not taking certain medications like anticoagulants (blood thinners) or loop diuretics.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06318988Not yet recruiting
Comparing treatments for chronic vein problems

This study compares different treatments for chronic venous disease (a condition where leg veins don't work properly, causing pain, swelling, and varicose veins). It aims to see which treatments work best, so you might get access to a range of options under careful medical supervision.

NCT07165340Enrolling by invitation· Phase 1/Phase 2
Physiotherapy for leg swelling from vein disease

This study tests whether adding a special physiotherapy program can help reduce leg swelling in people with vein disease. If you have swelling from varicose veins or other vein problems and have not tried certain treatments before, you may be able to join.

Houston, Texas
NCT07737236Recruiting
Ruscus study for symptom relief in chronic vein problems

This study tests a natural plant extract called Ruscus to see if it helps control symptoms of chronic venous insufficiency, a condition where leg veins have trouble moving blood back to the heart. It is for people who are already starting this treatment as part of their regular care.

Ankara, Ankara
NCT07362719Recruiting
Thermal cure for severe leg vein problems

This study tests if a 3-week thermal spa treatment can improve symptoms of severe chronic venous insufficiency (vein problems in your legs that cause swelling, skin changes, and risk of leg ulcers). It may help if you have serious vein issues but no open ulcers.

Amnéville
NCT07777978Recruiting
Home exercise and education for chronic venous insufficiency

This study tests a structured home-based exercise and education program for people with chronic venous insufficiency – a condition where veins in the legs have trouble sending blood back to the heart. If you qualify, you would do the program for 12 weeks to see if it helps improve your symptoms.

Bolu, Bolu
NCT07609927Not yet recruiting· Phase 2/Phase 3
Study of the enVVe Vein Valve System for Deep Vein Reflux

This trial tests an investigational device called the enVVe System to treat leg symptoms caused by damaged vein valves deep in the leg. If you have persistent leg pain, swelling, or skin changes despite using compression stockings, this study might help you. The device is placed into the vein to improve blood flow back to the heart.

Hear when a new Chronic Venous Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.